Determinants of utilization of cryopreservation of germ cells in adolescent cancer patients in four European countries

Authors:
  • PEPan Care L I F E
    Pan Care L I F E

Abstract
Infertility is a relevant late-effect following cancer treatment; yet, a large proportion of survivors cannot recall having been informed of this risk. In an intervention study, we examined if and how supportive patient information material on fertility/fertility-preserving measures influences utilization of cryopreservation in adolescent cancer patients. The control group, recruited 03/2014–01/2016, received the usual patient education at initial diagnosis. The intervention group, recruited 04/2016–10/2017, received patient education supported by a fertility flyer and brochure. Patients and parents were each asked questions on utilization of cryopreservation in a questionnaire 3 and 6 months after initial diagnosis. Patient core and therapy data were obtained from medical records. Overall, cryopreservation rates showed no significant difference between the control (32.7%, n = 37/113) and intervention group (36.6%, n = 37/101). In the control group, cryopreservation was associated with gender (OR 0.100, CI 0.023–0.427), age (OR 1.559, CI 1.077–2.258) and recalling information on fertility protection (OR 33.663, CI 2.100–539.574); in the intervention group, cryopreservation was related to gender (OR 0.093, CI 0.026–0.330) and the estimated infertility risk (OR 43.665, CI 2.157–883.974).
Funding Information
  • European Union's Seventh Framework Programme for research, technological development and demonstration; PanCareLIFE WP2b (602030)
  • Berliner Krebsgesellschaft (EKPS201607)
  • KINDERHILFE - Hilfe für krebs- und schwerkranke Kinder e.V.
  • Clinician Scientist Programm Charité - Universitätsmedizin Berlin and Berlin Institute of Health

This publication has 23 references indexed in Scilit: